Antiemetics
Leadership
Chair
Hirotoshi Iihara, PhD
Japan
Vice-Chair
Mary Lou Affronti, DNP, RN, MHSc, ANP, FAAN
USA
Mission and Goals
The Antiemetics Study Group was originally established as a subcommittee of MASCC to address the control of nausea and vomiting induced by chemotherapy and radiotherapy. At the 1995 MASCC Annual Meeting in Luxembourg, the group organized a consensus conference on the use of antiemetics and identified eight major issues that served as the basis for the Consensus Conference held in Perugia, Italy, 28-29 April 1997. Results were published in the ESMO journal, Annals of Oncology (Ann Oncol.1998; 9: 811-819).
In the following years, the study group has worked on guideline updates and practice-changing programs such as the MASCC Antiemesis Tool development, globally used for the patient’s self-assessment of nausea and vomiting issues.
Guideline updates, including those published jointly with ESMO, are highlighted in the table below.
| Year | Society | Location | Steering Committee | Publications |
|---|---|---|---|---|
| 1997 | MASCC | Perugia | Gralla RJ, Roila F, Tonato M |
Support Care Cancer: 1998 (12) Ann Oncol: 1998 (1) |
| 2004 | MASCC | Perugia | Gralla RJ, Roila F, Tonato M |
Support Care Cancer: 2005 (11) Ann Oncol: 2006 (1) |
| 2009 | MASCC/ESMO | Perugia | Gralla RJ, Tonato M, Roila F, Herrstedt J. |
Support Care Cancer: 2011 (11) Ann Oncol: 2010 (1) |
| 2015 | MASCC/ESMO | Copenhagen | Aapro MS, Gralla RJ, Herrstedt J, Roila F Molassiotis A |
Support Care Cancer: 2017 (10) Ann Oncol: 2016 (1) |
| 2022 | MASCC/ESMO | Toronto | Herrstedt J, Clark-Snow R, Ruhlmann C, Jordan K, Scotté F |
Support Care Cancer: 2023 (10) ESMO Open: 2023 (1) |
The Antiemetics Study Group is facing evolution of anticancer treatments, comprehension of individual risk factors, patients’ involvement in cancer education and evolutions of patient pathways. New members are always welcome to share their vision with global leaders on the topic.
How to Join
To join a study group, you must be a MASCC member. Members can belong to up to three study groups.
